LB Pharmaceuticals Inc Common Stock

Healthcare

NASDAQ:LBRX · NASDAQ Global Select

Market Cap $888.98M Beta 0.71 P/E (TTM) -21.4

$30.00 -1.30%

-$0.39 today

52W Low $13.36High $33.47

Vol 0.50M · Avg 0.23M

EPS (TTM) -$1.39Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+73.41%

Period High

$32.88

Period Low

$14.61

Latest

$30.00

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Design Therapeutics, Inc.

NASDAQ:DSGN

$753.86M

Solid Biosciences Inc.

NASDAQ:SLDB

$591.89M

Annexon, Inc.

NASDAQ:ANNX

$582.64M

Autolus Therapeutics plc

NASDAQ:AUTL

$411.19M

Aura Biosciences, Inc.

NASDAQ:AURA

$396.75M

DBV Technologies S.A.

NASDAQ:DBVT

$381.21M

Rocket Pharmaceuticals, Inc.

NASDAQ:RCKT

$352.15M

Larimar Therapeutics, Inc.

NASDAQ:LRMR

$300.81M

Altimmune, Inc.

NASDAQ:ALT

$239.62M

Korro Bio, Inc.

NASDAQ:KRRO

$126.76M

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.